股本结构
单位：万股
| 公告日期 | 2024-04-19 | 2024-04-19 | 2024-02-27 | 2024-02-27 | 2023-08-03 | 2023-05-15 |
|---|---|---|---|---|---|---|
| 证券总股本 | 6215.36 | 6214.10 | 6193.52 | 6191.54 | 6182.26 | 6175.90 |
| 普通股本 | 6215.36 | 6214.10 | 6193.52 | 6191.54 | 6182.26 | 6175.90 |
| 优先股 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 |
| 其他 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 |
| 变动日期 | 2024-04-18 | 2024-03-31 | 2024-02-20 | 2023-12-31 | 2023-06-30 | 2023-03-31 |
注释：中概股证券总股本=普通股股本/
存托凭证比例
历史变动
| 公告日期 | 变动后普通股本（万股） | 变动后优先股（万股） | 变动原因 | 变动日期 |
|---|---|---|---|---|
| 2024-04-19 | 6215.36 | 未披露 | 定期报告 | 2024-04-18 |
| 2024-04-19 | 6214.10 | 未披露 | 定期报告 | 2024-03-31 |
| 2024-02-27 | 6193.52 | 未披露 | 定期报告 | 2024-02-20 |
| 2024-02-27 | 6191.54 | 未披露 |
更多>>
From December 31, 2022 to December 31, 2023
Vesting of restricted stock awards
Issuance of common stock in connection with public offering, net of issuance costs
Issuance of common stock under employee benefit plans
|
2023-12-31 |
| 2023-08-03 | 6182.26 | 未披露 |
更多>>
From March 31, 2023 to June 30, 2023
Issuance of common stock under employee benefit plans
Vesting of restricted stock awards
|
2023-06-30 |
| 2023-05-15 | 6175.90 | 未披露 |
更多>>
From December 31, 2022 to March 31, 2023
Vesting of restricted stock awards
Issuance of common stock in connection with public offering, net of issuance costs
Issuance of common stock under employee benefit plans
|
2023-03-31 |
| 2023-03-09 | 6175.90 | 未披露 | 定期报告 | 2023-03-02 |
| 2023-01-18 | 6166.68 | 未披露 |
更多>>
Common stock offered 9,615,384 shares by the company
|
2023-01-20 |
| 2023-03-09 | 5209.92 | 未披露 |
更多>>
From December 31, 2021 to December 31, 2022
Vesting of restricted stock awards
Issuance of common stock in connection with public offering, net of issuance costs
Issuance of common stock under employee benefit plans
|
2022-12-31 |
| 2022-11-08 | 5205.14 | 未披露 | 定期报告 | 2022-11-01 |
| 2022-11-08 | 5204.99 | 未披露 |
更多>>
From June 30, 2022 to September 30, 2022
Issuance of common stock in connection with public offering, net of issuance costs
Issuance of common stock under employee benefit plans
|
2022-09-30 |
| 2022-08-23 | 5203.76 | 未披露 |
更多>>
On August 19, 2022, the underwriters of the previously announced underwritten public offering of common stock of Fulcrum Therapeutics, Inc., or Fulcrum, exercised in full their option to purchase an additional 1,438,618 shares from Fulcrum at the public offering price of $7.82 per share, resulting in additional net proceeds to Fulcrum of approximately $10.6 million, or approximately $80.9 million in total net proceeds after taking into account the exercise of the underwriters’ option, in each case after deducting underwriting discounts and commissions and estimated offering expenses. The exercise of the overallotment option closed on August 23, 2022.
|
2022-08-23 |
| 2022-08-18 | 5059.90 | 未披露 |
更多>>
1.Common stock offered by 9,590,792 shares of common stock
2.The number of shares of common stock shown above to be outstanding immediately after this offering is based on 41,008,205 shares of common stock outstanding as of June 30, 2022
|
2022-08-18 |
| 2022-08-11 | 4100.94 | 未披露 | 定期报告 | 2022-08-04 |
| 2022-08-11 | 4100.82 | 未披露 |
更多>>
From March 31, 2022 to June 30, 2022
Issuance of common stock under employee benefit plans
Vesting of restricted stock awards
|
2022-06-30 |
| 2022-05-09 | 4084.82 | 未披露 | 定期报告 | 2022-05-02 |
| 2022-04-28 | 4081.79 | 未披露 | 定期报告 | 2022-04-11 |
| 2022-05-09 | 4068.36 | 未披露 |
更多>>
From December 31, 2021 to March 31, 2022
Issuance of common stock under employee benefit plans
Vesting of restricted stock awards
|
2022-03-31 |
| 2022-03-03 | 4063.72 | 未披露 | 定期报告 | 2022-02-24 |
| 2022-03-03 | 4062.62 | 未披露 |
更多>>
From December 31, 2020 to December 31, 2021
Issuance of common stock in connection with public offerings, net of issuance costs
Issuance of common stock under employee benefit plans
Vesting of restricted stock awards
Repurchase of unvested restricted stock awards
Retirement of treasury shares
|
2021-12-31 |
| 2021-11-04 | 4054.88 | 未披露 | 定期报告 | 2021-10-28 |
| 2021-11-04 | 4052.60 | 未披露 |
更多>>
From June 30, 2021 to September 30, 2021
Issuance of common stock in connection with public offering, net of issuance costs
Issuance of common stock under employee benefit plans
Vesting of restricted stock awards
Repurchase of unvested restricted stock awards
Retirement of treasury shares
|
2021-09-30 |
| 2021-08-16 | 3930.84 | 未披露 |
更多>>
1.Common Stock Offered 6,600,000 shares.
2.The number of shares of common stock to be outstanding immediately after this offering is based on 32,708,425 shares of common stock outstanding as of July 31, 2021.
|
2021-08-16 |
| 2021-08-11 | 3270.84 | 未披露 | 定期报告 | 2021-07-31 |
| 2021-08-10 | 3265.97 | 未披露 |
更多>>
From March 31, 2021 to June 30, 2021
Issuance of common stock under employee benefit plans
Vesting of restricted stock awards
Repurchase of unvested restricted stock awards
Retirement of treasury shares
|
2021-06-30 |
| 2021-05-06 | 3267.96 | 未披露 | 定期报告 | 2021-04-29 |
| 2021-04-29 | 3267.75 | 未披露 | 定期报告 | 2021-04-12 |
| 2021-05-06 | 3259.44 | 未披露 |
更多>>
From December 31, 2020 to March 31, 2021
Issuance of common stock in connection with follow-on offering, net of issuance costs
Issuance of common stock under employee benefit plans
Vesting of restricted stock awards
Repurchase of unvested restricted stock awards
Retirement of treasury shares
|
2021-03-31 |
| 2021-03-04 | 3267.22 | 未披露 | 定期报告 | 2021-02-25 |
| 2021-01-22 | 3206.74 | 未披露 |
更多>>
1.Common Stock Offered 4,000,000 shares.
2.The number of shares of common stock to be outstanding immediately after this offering is based on 28,067,434 shares of common stock outstanding as of January 8, 2021, including 115,646 shares of unvested restricted stock subject to repurchase.
|
2021-01-22 |
| 2021-01-19 | 2795.18 | 未披露 | 定期报告 | 2021-01-08 |
| 2021-03-04 | 2794.16 | 未披露 |
更多>>
From December 31,2019 to December 31,2020
Issuance of common stock in connection with private placement, net of issuance costs
Issuance of common stock in “at-the-market” offering, net of issuance costs
Vesting of restricted stock awards
Issuance of common stock under employee benefit plans
Repurchase of unvested restricted stock awards
Retirement of treasury shares
|
2020-12-31 |
| 2020-11-10 | 2746.26 | 未披露 | 定期报告 | 2020-11-04 |
| 2020-11-10 | 2727.80 | 未披露 |
更多>>
from June 30, 2020 to September 30, 2020
Repurchase of unvested restricted stock awards
Issuance of common stock
Retirement of treasury shares
|
2020-09-30 |
| 2020-08-11 | 2745.28 | 未披露 | 定期报告 | 2020-08-04 |
| 2020-08-11 | 2722.38 | 未披露 |
更多>>
from March 31, 2020 to June 30, 2020
Issuance of common stock
Issuance of common stock in connection with private placement, net of placement agent fees and offering costs
Repurchase of unvested restricted stock awards
Retirement of treasury shares
|
2020-06-30 |
| 2020-06-22 | 2742.48 | 未披露 | 定期报告 | 2020-06-15 |
| 2020-05-13 | 2337.32 | 未披露 | 定期报告 | 2020-05-08 |
| 2020-04-29 | 2336.32 | 未披露 | 定期报告 | 2020-04-14 |
| 2020-05-13 | 2279.31 | 未披露 |
更多>>
From December 31, 2019 to March 31, 2020
Change in value of ordinary shares subject to possible redemption
|
2020-03-31 |
| 2020-03-05 | 2335.70 | 未披露 | 定期报告 | 2020-02-28 |
| 2020-03-05 | 2265.44 | 未披露 |
更多>>
From December 31, 2018 to December 31, 2019
Issuance of Series B convertible preferred stock in connection with asset acquisition, net of issuance costs
Conversion of convertible preferred stock into common stock
Initial public offering, net of underwriting discounts, commissions and offering costs
Issuance of common stock
Repurchase of unvested restricted stock awards
Retirement of treasury shares
|
2019-12-31 |
| 2019-11-14 | 2334.05 | 未披露 | 定期报告 | 2019-11-08 |
| 2019-11-14 | 2255.79 | 未披露 |
更多>>
From June 30, 2019 to September 30, 2019
Initial public offering, net of underwriting discounts, commissions and offering costs
Conversion of convertible preferred stock into common stock
Issuance of common stock
Repurchase of unvested restricted stock awards
Retirement of treasury shares
|
2019-09-30 |
| 2019-08-26 | 2334.04 | 未披露 | 定期报告 | 2019-08-23 |
| 2019-07-18 | 2334.00 | 未披露 |
更多>>
1.Common stock offered 4,500,000 shares
2.The number of shares of our common stock to be outstanding after this offering is based on 2,768,596 shares of our common stock outstanding as of June 30, 2019
3.a one-for-seven reverse stock split of our common stock that became effective on July 5, 2019
|
2019-07-18 |
| 2019-08-26 | 187.03 | 11250.00 |
更多>>
from March 31, 2019 to June 30, 2019
Issuance of common stock
Repurchase of unvested restricted stock awards
Retirement of treasury shares
|
2019-06-30 |
| 2019-06-21 | 12455.42 | 未披露 |
更多>>
from March 31, 2018 to March 31, 2019
Issuance of Series B convertible preferred stock in connection with asset acquisition, net of issuance costs of $34
Issuance of common stock
Repurchase of unvested restricted stock awards
Retirement of treasury shares
Conversion of convertible preferred stock into common stock
|
2019-03-31 |
From December 31, 2022 to December 31, 2023
Vesting of restricted stock awards
Issuance of common stock in connection with public offering, net of issuance costs
Issuance of common stock under employee benefit plans
From March 31, 2023 to June 30, 2023
Issuance of common stock under employee benefit plans
Vesting of restricted stock awards
From December 31, 2022 to March 31, 2023
Vesting of restricted stock awards
Issuance of common stock in connection with public offering, net of issuance costs
Issuance of common stock under employee benefit plans
Common stock offered 9,615,384 shares by the company
From December 31, 2021 to December 31, 2022
Vesting of restricted stock awards
Issuance of common stock in connection with public offering, net of issuance costs
Issuance of common stock under employee benefit plans
From June 30, 2022 to September 30, 2022
Issuance of common stock in connection with public offering, net of issuance costs
Issuance of common stock under employee benefit plans
On August 19, 2022, the underwriters of the previously announced underwritten public offering of common stock of Fulcrum Therapeutics, Inc., or Fulcrum, exercised in full their option to purchase an additional 1,438,618 shares from Fulcrum at the public offering price of $7.82 per share, resulting in additional net proceeds to Fulcrum of approximately $10.6 million, or approximately $80.9 million in total net proceeds after taking into account the exercise of the underwriters’ option, in each case after deducting underwriting discounts and commissions and estimated offering expenses. The exercise of the overallotment option closed on August 23, 2022.
1.Common stock offered by 9,590,792 shares of common stock
2.The number of shares of common stock shown above to be outstanding immediately after this offering is based on 41,008,205 shares of common stock outstanding as of June 30, 2022
From March 31, 2022 to June 30, 2022
Issuance of common stock under employee benefit plans
Vesting of restricted stock awards
From December 31, 2021 to March 31, 2022
Issuance of common stock under employee benefit plans
Vesting of restricted stock awards
From December 31, 2020 to December 31, 2021
Issuance of common stock in connection with public offerings, net of issuance costs
Issuance of common stock under employee benefit plans
Vesting of restricted stock awards
Repurchase of unvested restricted stock awards
Retirement of treasury shares
From June 30, 2021 to September 30, 2021
Issuance of common stock in connection with public offering, net of issuance costs
Issuance of common stock under employee benefit plans
Vesting of restricted stock awards
Repurchase of unvested restricted stock awards
Retirement of treasury shares
1.Common Stock Offered 6,600,000 shares.
2.The number of shares of common stock to be outstanding immediately after this offering is based on 32,708,425 shares of common stock outstanding as of July 31, 2021.
From March 31, 2021 to June 30, 2021
Issuance of common stock under employee benefit plans
Vesting of restricted stock awards
Repurchase of unvested restricted stock awards
Retirement of treasury shares
From December 31, 2020 to March 31, 2021
Issuance of common stock in connection with follow-on offering, net of issuance costs
Issuance of common stock under employee benefit plans
Vesting of restricted stock awards
Repurchase of unvested restricted stock awards
Retirement of treasury shares
1.Common Stock Offered 4,000,000 shares.
2.The number of shares of common stock to be outstanding immediately after this offering is based on 28,067,434 shares of common stock outstanding as of January 8, 2021, including 115,646 shares of unvested restricted stock subject to repurchase.
From December 31,2019 to December 31,2020
Issuance of common stock in connection with private placement, net of issuance costs
Issuance of common stock in “at-the-market” offering, net of issuance costs
Vesting of restricted stock awards
Issuance of common stock under employee benefit plans
Repurchase of unvested restricted stock awards
Retirement of treasury shares
from June 30, 2020 to September 30, 2020
Repurchase of unvested restricted stock awards
Issuance of common stock
Retirement of treasury shares
from March 31, 2020 to June 30, 2020
Issuance of common stock
Issuance of common stock in connection with private placement, net of placement agent fees and offering costs
Repurchase of unvested restricted stock awards
Retirement of treasury shares
From December 31, 2019 to March 31, 2020
Change in value of ordinary shares subject to possible redemption
From December 31, 2018 to December 31, 2019
Issuance of Series B convertible preferred stock in connection with asset acquisition, net of issuance costs
Conversion of convertible preferred stock into common stock
Initial public offering, net of underwriting discounts, commissions and offering costs
Issuance of common stock
Repurchase of unvested restricted stock awards
Retirement of treasury shares
From June 30, 2019 to September 30, 2019
Initial public offering, net of underwriting discounts, commissions and offering costs
Conversion of convertible preferred stock into common stock
Issuance of common stock
Repurchase of unvested restricted stock awards
Retirement of treasury shares
1.Common stock offered 4,500,000 shares
2.The number of shares of our common stock to be outstanding after this offering is based on 2,768,596 shares of our common stock outstanding as of June 30, 2019
3.a one-for-seven reverse stock split of our common stock that became effective on July 5, 2019
from March 31, 2019 to June 30, 2019
Issuance of common stock
Repurchase of unvested restricted stock awards
Retirement of treasury shares
from March 31, 2018 to March 31, 2019
Issuance of Series B convertible preferred stock in connection with asset acquisition, net of issuance costs of $34
Issuance of common stock
Repurchase of unvested restricted stock awards
Retirement of treasury shares
Conversion of convertible preferred stock into common stock